Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Hypertrophic cardiomyopathy (HCM)
Heart failure (HF)
Paroxysmal supraventricular tachycardia (PSVT)
Atrial fibrillation (AFib)
Hypertension
Dry eye disease (DED)
Presbyopia
Our expertise
Overview
Our partners
China opportunities
Join us
Media
Contact
简体中文
Search
简体中文
Navigation
Media
25 May 2023
Milestone Pharmaceuticals Announces Presentation of Data from Analysis of Etripamil Nasal Spray in Patients Experiencing Atrial Fibrillation with Rapid Ventricular Rate
Read article
23 May 2023
Cytokinetics Presents New Data in Patients With Non-Obstructive HCM From Cohort 4 of REDWOOD-HCM in Late-Breaking Clinical Trial Session at The European Society of Cardiology Heart Failure 2023 Congress
Read article
06 Apr 2023
JIXING Ophthalmology Product Varenicline Solution Nasal Spray Is Available at Boao Super Hospital in Hainan Province
Read article
08 Mar 2023
CYTOKINETICS, PRESENTS POSITIVE RESULTS FROM COHORT 4 OF REDWOOD-HCM AND LONG-TERM RESULTS FROM FOREST-HCM AT THE AMERICAN COLLEGE OF CARDIOLOGY 72ND ANNUAL SCIENTIFIC SESSION
Read article
07 Mar 2023
JIXING Presents the Latest Research Data of Cardiovascular Asset JX09 at the American College of Cardiology Annual Congress 2023
Read article
06 Feb 2023
JIXING Announces Acquisition of an Innovative Cardiovascular Asset for Global Development
Read article
Load more